Oncology News

Selvita , the largest independent drug discovery company in Central and Eastern Europe, will present new data at poster sessions at AACR Annual Meeting 2014, which will take place on April 5 - 9, 2014 at San Diego Convention Center, San Diego, California, USA.

WHEN faced with a devastating diagnosis and your whole world is crumbling around you, he has the calming voice and listening ear that gets you through.

The National Cancer Institute has progressed from a rate of nine months of survival to 30 with personalized treatments for patients diagnosed with lung cancer in metastatic stage, i.e., when the disease has spread to different parts of the body.

When Dr. Jeffery Ward joined a community oncology practice in Seattle, it had three doctors.

Fifteen years ago, a handful of poorly constructed, clearly biased studies purported to show that prayer was a legitimate medical tool.

CANCER patients paying more than $1000 a week for drugs needed to help keep them alive are demanding the Abbott Government act Severely ill Melbourne patients, leading oncologists and businessman Ron Walker want a cancer drug fund to save the lives of those unable to afford drugs, some costing more than $100,000 a year.

The annual meeting of the American Association for Cancer Research, which convenes in San Diego on April 5, is viewed by most drug-industry watchers as a second-tier medical conference.

Cancer patients from as far as Horsham have been receiving treatment in the new oncology unit at Stawell Hospital's state-of-the-art Community Rehabilitation Centre.

St. Luke's University Health Network is one of three sites nationwide chosen to enroll patients in a new study using the therapeutic agent PV-10 for late-stage liver cancer.

Champions Oncology , a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced it will report its financial and operational results for the third quarter ended January 31, 2014 on Thursday, March 13, 2014, after market close.

Journal of the National Cancer Institute , Vol. 103, No. 1. , pp. 16-20, doi:10.1093/jnci/djq463 The approval of a new drug for cancer treatment by the regulatory authorities, such as the United States Food and Drug Administration or European Medicines Agency, is usually based on the positive results of one or more randomized phase III clinical ... (more)

Hello, friends and residents of Naperville. We've turned the page on February, which is always a special month to remember those in your lives that are near and dear to you.

With the death last week of Yale surgeon Dr. Sherwin Nuland, the New York Times obituary credited his 1993 best-selling book, "How We Die ," with being the catalyst that spurred many conversations about end-of-life care.

Thank you for your interest in the Sr. Oncology Nurse Practitioner. To begin the application process, please enter your information below.

As Aimee Parani puts it: "It's been a helluva year." Marking one year since her diagnosis for breast cancer while pregnant, Aimee Parani has seen numerous life-altering changes in 12 short months.

In association with its 50th anniversary, the American Society of Clinical Oncology has named Dr. Daniel D. Von Hoff one of ASCO's 50 Oncology Luminaries, celebrating 50 doctors who over the past half-century have significantly advanced cancer care.

Signalling pathways such as Hedgehog , Wnt, Notch, bone morphogenetic protein and transforming growth factor-I2 hold a central position in regulation of vertebrate development by controlling vital processes such as migration, differentiation and proliferation.

Greenville Health System's Institute for Translational Oncology Research has just launched the nation's first center dedicated exclusively to the treatment and research of rare cancers.

The second time, Bash wanted to explore all her options - including an experimental treatment at Penn Medicine that manipulates a patient's tumor cells to trigger an immune response.

Lyle Southam, 62, enrolled in the CHALLENGE study in 2013 after completing treatment for colon cancer.